Opinion
Video
Author(s):
A panel of experts discuss the variables of dosage and patient adherence in regards to managing toxicities from CDK4/6 inhibitors.
Video content above is prompted by the following question(s):
Breast Cancer Outcomes Improved in States With Medicaid Expansion
Managing Germline Mutations in Hereditary Breast Cancer Risk